Equities

Ami Organics Ltd

AMIORG:NSI

Ami Organics Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,631.30
  • Today's Change91.30 / 5.93%
  • Shares traded663.09k
  • 1 Year change+27.05%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 11:27 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Ami Organics Ltd had net income fall -48.65% from 832.90m to 427.73m despite a 16.33% increase in revenues from 6.17bn to 7.17bn. An increase in the cost of goods sold as a percentage of sales from 53.65% to 57.38% was a component in the falling net income despite rising revenues.
Gross margin41.39%
Net profit margin5.56%
Operating margin9.91%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in INRView more

In 2024, Ami Organics Ltd did not generate a significant amount of cash. Cash Flow from Financing totalled 2.39bn or 33.36% of revenues. In addition the company generated 1.25bn in cash from operations while cash used for investing totalled 3.65bn.
Cash flow per share13.63
Price/Cash flow per share105.38
Book value per share--
Tangible book value per share--
More ▼

Balance sheet in INRView more

Ami Organics Ltd uses little or no debt in its capital structure.
Current ratio--
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in INR

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -48.97%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
Div yield(5 year avg)0.18%
Div growth rate (5 year)--
Payout ratio (TTM)0.00%
EPS growth(5 years)12.78
EPS (TTM) vs
TTM 1 year ago
-67.72
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.